{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:31:49Z","timestamp":1793331109800,"version":"4.5.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"6","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,26]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Congenital fibrinogen deficiency (CFD) is a rare bleeding disorder caused by mutations in FGA, FGB, and FGG. We sought to comprehensively characterize patients with CFD using PRO-RBDD (Prospective Rare Bleeding Disorders Database). Clinical phenotypes, laboratory, and genetic features were investigated using retrospective data from the PRO-RBDD. Patients were classified from asymptomatic to grade 3 based on their bleeding severity. In\u00a0addition, FGA, FGB, and FGG were sequenced to find causative variants. A total of 166 CFD cases from 16 countries were included, of whom 123 (30 afibrinogenemia, 33 hypofibrinogenemia, 55 dysfibrinogenemia, and 5 hypodysfibrinogenemia) were well characterized. Considering the previously established factor activity and antigen level thresholds, bleeding severity was correctly identified in 58% of the cases. The rates of thrombotic events among afibrinogenemic and hypofibrinogenemic patients were relatively similar (11% and 10%, respectively) and surprisingly higher than in dysfibrinogenemic cases. The rate of spontaneous abortions among 68 pregnancies was 31%, including 86% in dysfibrinogenemic women and 14% with hypofibrinogenemia. Eighty-six patients received treatment (69 on-demand and\/or 17 on prophylaxis), with fibrinogen concentrates being the most frequently used product. Genetic analysis was available for 91 cases and 41 distinct variants were identified. Hotspot variants (FGG,\u00a0p.Arg301Cys\/His and FGA, p.Arg35Cys\/His) were present in 51% of dysfibrinogenemia. Obstetric complications were commonly observed in dysfibrinogenemia. This large multicenter study provided a comprehensive insight into the clinical, laboratory, and genetic history of patients with CFDs. We conclude that bleeding severity grades were in agreement with the established factor activity threshold in nearly half of the cases with quantitative defects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012186","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T01:21:42Z","timestamp":1706577702000},"page":"1392-1404","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-4456","authenticated-orcid":false,"given":"Samin","family":"Mohsenian","sequence":"first","affiliation":[{"name":"1Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Palla","sequence":"additional","affiliation":[{"name":"1Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-7556","authenticated-orcid":false,"given":"Marzia","family":"Menegatti","sequence":"additional","affiliation":[{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lecchi","sequence":"additional","affiliation":[{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7910-933X","authenticated-orcid":false,"given":"Alessandro","family":"Casini","sequence":"additional","affiliation":[{"name":"3Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-4195","authenticated-orcid":false,"given":"Marguerite","family":"Neerman-Arbez","sequence":"additional","affiliation":[{"name":"4Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-0619","authenticated-orcid":false,"given":"Rosanna","family":"Asselta","sequence":"additional","affiliation":[{"name":"5Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"6IRCCS Humanitas Research Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4539-545X","authenticated-orcid":false,"given":"Sara","family":"Scardo","sequence":"additional","affiliation":[{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-7519","authenticated-orcid":false,"given":"Simona Maria","family":"Siboni","sequence":"additional","affiliation":[{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Blatny","sequence":"additional","affiliation":[{"name":"7Department of Paediatrics Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Zapletal","sequence":"additional","affiliation":[{"name":"7Department of Paediatrics Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-3254","authenticated-orcid":false,"given":"Jean-Francois","family":"Schved","sequence":"additional","affiliation":[{"name":"8Department of Biological Hematology, CHU Montpellier, Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-6177","authenticated-orcid":false,"given":"Muriel","family":"Giansily-Blaizot","sequence":"additional","affiliation":[{"name":"8Department of Biological Hematology, CHU Montpellier, Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Halimeh","sequence":"additional","affiliation":[{"name":"9Coagulation Centre Rhein-Ruhr, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ayman","family":"Daoud","sequence":"additional","affiliation":[{"name":"9Coagulation Centre Rhein-Ruhr, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Platokouki","sequence":"additional","affiliation":[{"name":"10Haemophilia-Centre-Haemostasis Unit, Aghia Sophia Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Pergantou","sequence":"additional","affiliation":[{"name":"10Haemophilia-Centre-Haemostasis Unit, Aghia Sophia Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-6033","authenticated-orcid":false,"given":"Roger E. G.","family":"Schutgens","sequence":"additional","affiliation":[{"name":"11Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Van Haaften-Spoor","sequence":"additional","affiliation":[{"name":"11Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brons","sequence":"additional","affiliation":[{"name":"12Department of Pediatric Hematology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Laros-van Gorkom","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Van Pinxten","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Borhany","sequence":"additional","affiliation":[{"name":"14Clinical Hematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Fatima","sequence":"additional","affiliation":[{"name":"14Clinical Hematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Mikovic","sequence":"additional","affiliation":[{"name":"15Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-2826","authenticated-orcid":false,"given":"Marko","family":"Saracevic","sequence":"additional","affiliation":[{"name":"15Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl Nihal","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"16Pediatric Hematology Department, Istinye University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u0131lmaz","family":"Ay","sequence":"additional","affiliation":[{"name":"17University of Health Sciences Kartal Health Application and Research Center, Pediatric Hematology and Oncology Clinic, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-7939","authenticated-orcid":false,"given":"Michael","family":"Makris","sequence":"additional","affiliation":[{"name":"18Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl","family":"Lockley","sequence":"additional","affiliation":[{"name":"18Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-511X","authenticated-orcid":false,"given":"Andrew","family":"Mumford","sequence":"additional","affiliation":[{"name":"19School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Harvey","sequence":"additional","affiliation":[{"name":"19School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Austin","sequence":"additional","affiliation":[{"name":"20Department of Haematology, Guys and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shapiro","sequence":"additional","affiliation":[{"name":"21Indiana Hemophilia and Thrombosis Center, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Williamson","sequence":"additional","affiliation":[{"name":"21Indiana Hemophilia and Thrombosis Center, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McGuinn","sequence":"additional","affiliation":[{"name":"21Indiana Hemophilia and Thrombosis Center, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene","family":"Goldberg","sequence":"additional","affiliation":[{"name":"22Division of Pediatric Hematology Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-0359","authenticated-orcid":false,"given":"Philippe","family":"De Moerloose","sequence":"additional","affiliation":[{"name":"3Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[{"name":"1Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"},{"name":"2Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"issue":"5","key":"2024032513103475200_bib1","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","article-title":"Human plasma fibrinogen is synthesized in the liver","volume":"109","author":"Tennent","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2024032513103475200_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1538-7836.2008.03242.x","article-title":"Recommendations for nomenclature on fibrinogen and fibrin","volume":"7","author":"Medved","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024032513103475200_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia","volume":"133","author":"Menegatti","year":"2019","journal-title":"Blood"},{"issue":"9","key":"2024032513103475200_bib4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"Casini","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"13","key":"2024032513103475200_bib5","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2024032513103475200_bib6","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/ijms18122711","article-title":"Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of A\u03b1, B\u03b2, and \u03b3 chains","volume":"18","author":"Paraboschi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024032513103475200_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","article-title":"Rare inherited disorders of fibrinogen","volume":"14","author":"Acharya","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"2024032513103475200_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0036-1571339","article-title":"Clinical features and management of congenital fibrinogen deficiencies","volume":"42","author":"Casini","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2024032513103475200_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2516.2009.01939.x","article-title":"Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo-and afibrinogenemia","volume":"15","author":"Castaman","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"2024032513103475200_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0036-1581103","article-title":"Severe thrombotic complications in congenital afibrinogenemia: a pathophysiological and management dilemma","volume":"42","author":"Santoro","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2024032513103475200_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-019-01991-x","article-title":"Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the \u03b3-chain (p. Glu275Stop)","volume":"50","author":"Simurda","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"1","key":"2024032513103475200_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"issue":"4","key":"2024032513103475200_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","article-title":"Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia","volume":"55","author":"Zhou","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2024032513103475200_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"Casini","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2024032513103475200_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.thromres.2013.08.023","article-title":"The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading","volume":"132","author":"Snir","year":"2013","journal-title":"Thromb Res"},{"issue":"5","key":"2024032513103475200_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1389450054546006","article-title":"Maternal fibrinogen is necessary for embryonic development","volume":"6","author":"Iwaki","year":"2005","journal-title":"Curr Drug Targets"},{"issue":"3","key":"2024032513103475200_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)64923-1","article-title":"Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse","volume":"160","author":"Iwaki","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"2024032513103475200_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024032513103475200_bib19","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"2024032513103475200_bib20","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024032513103475200_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2016.11.008","article-title":"Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders","volume":"148","author":"Palla","year":"2016","journal-title":"Thromb Res"},{"issue":"13","key":"2024032513103475200_bib22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"\u0160r\u00e1mek","year":"1995","journal-title":"Arch Intern Med"},{"issue":"10","key":"2024032513103475200_bib23","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/j.1538-7836.2006.02094.x","article-title":"The molecular basis of quantitative fibrinogen disorders","volume":"4","author":"Asselta","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024032513103475200_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2001.tb03495.x","article-title":"A\u00a0database for human fibrinogen variants","volume":"936","author":"Hanss","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2024032513103475200_bib25","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1055\/s-0038-1673685","article-title":"Mutational epidemiology of congenital fibrinogen disorders","volume":"118","author":"Casini","year":"2018","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024032513103475200_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms19010100","article-title":"Identification of two novel fibrinogen B\u03b2 chain mutations in two Slovak families with quantitative fibrinogen disorders","volume":"19","author":"Simurda","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024032513103475200_bib27","doi-asserted-by":"crossref","first-page":"103203","DOI":"10.1016\/j.transci.2021.103203","article-title":"Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders","volume":"60","author":"Mohsenian","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"suppl 3","key":"2024032513103475200_bib28","first-page":"s515","article-title":"The European Haemophilia Network (EUHANET)","volume":"12","author":"Makris","year":"2014","journal-title":"Blood Transfus"},{"issue":"11","key":"2024032513103475200_bib29","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/jth.13851","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds: reply","volume":"15","author":"Menegatti","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024032513103475200_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0036-1571340","article-title":"Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders","volume":"42","author":"Neerman-Arbez","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2024032513103475200_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/hae.14773","article-title":"Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies","volume":"29","author":"Mohsenian","year":"2023","journal-title":"Haemophilia"},{"issue":"20","key":"2024032513103475200_bib32","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"Saes","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2024032513103475200_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/hae.12143","article-title":"Molecular basis of quantitative fibrinogen disorders in 27 patients from I ndia","volume":"19","author":"Sumitha","year":"2013","journal-title":"Haemophilia"},{"issue":"1","key":"2024032513103475200_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"Lak","year":"1999","journal-title":"Br J Haematol"},{"key":"2024032513103475200_bib35","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.blre.2020.100793","article-title":"Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management","volume":"48","author":"Casini","year":"2021","journal-title":"Blood Rev"},{"issue":"5","key":"2024032513103475200_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/hae.13825","article-title":"Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review","volume":"25","author":"Valiton","year":"2019","journal-title":"Haemophilia"},{"issue":"4","key":"2024032513103475200_bib37","first-page":"1083","article-title":"Heterogeneity of genotype\u2013phenotype in congenital hypofibrinogenemia\u2014a review of case reports associated with bleeding and thrombosis","volume":"11","author":"Brunclikova","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"2024032513103475200_bib38","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1160\/TH12-05-0355","article-title":"Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans","volume":"108","author":"Marchi","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024032513103475200_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/ijms19010192","article-title":"Clinical consequences and molecular bases of low fibrinogen levels","volume":"19","author":"Neerman-Arbez","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2024032513103475200_bib40","first-page":"105","article-title":"Update on antithrombin I (fibrin)","volume":"98","author":"Mosesson","year":"2007","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024032513103475200_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders","volume":"44","author":"Korte","year":"2017","journal-title":"Transfus Med Hemother"},{"issue":"8","key":"2024032513103475200_bib42","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.jtha.2023.04.035","article-title":"Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study","volume":"21","author":"Hugon-Rodin","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024032513103475200_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/VHRM.S5305","article-title":"Treatment of congenital fibrinogen deficiency: overview and recent findings","volume":"5","author":"Tziomalos","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"2024032513103475200_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1160\/TH16-02-0082","article-title":"Thromboembolism in patients with congenital afibrinogenaemia","volume":"116","author":"Nagler","year":"2016","journal-title":"Thromb Haemost"},{"issue":"4","key":"2024032513103475200_bib45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1160\/TH14-06-0514","article-title":"Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data","volume":"113","author":"Solomon","year":"2015","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024032513103475200_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/humu.20839","article-title":"A\u00a0deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in\u00a0vitro with antisense oligonucleotide treatment","volume":"30","author":"Davis","year":"2009","journal-title":"Hum Mutat"},{"issue":"database issue","key":"2024032513103475200_bib47","doi-asserted-by":"crossref","first-page":"D115","DOI":"10.1093\/nar\/gkh131","article-title":"UniProt: the universal protein knowledgebase","volume":"32","author":"Apweiler","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2024032513103475200_bib48","first-page":"293","article-title":"Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids)","volume":"11","author":"Siebenlist","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"2024032513103475200_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13296","article-title":"Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders","volume":"103","author":"Castaman","year":"2019","journal-title":"Eur J Haematol"},{"issue":"5137","key":"2024032513103475200_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/218134a0","article-title":"Fibrinogen Detroit\u2014a molecular defect in the N-terminal disulphide knot of human fibrinogen?","volume":"218","author":"Blomb\u00e4ck","year":"1968","journal-title":"Nature"},{"issue":"6","key":"2024032513103475200_bib51","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/ijms19061597","article-title":"Human fibrinogen: molecular and genetic aspects of congenital disorders","volume":"19","author":"Tiscia","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024032513103475200_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"De Moerloose","year":"2013","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/6\/1392\/2218990\/blooda_adv-2023-012186-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/6\/1392\/2218990\/blooda_adv-2023-012186-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T13:11:34Z","timestamp":1711372294000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/6\/1392\/514755\/Congenital-fibrinogen-disorders-a-retrospective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012186","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}